The Insulin Glargine Market is Estimated To Witness Moderate Growth Owing To Increase In Diabetes Patients Globally
The Insulin Glargine Market is estimated to be valued at US$ 6178.14 Mn in 2023 and is expected to exhibit a CAGR of 0.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Insulin glargine is a long-acting insulin drug used to treat diabetes. It helps in controlling blood sugar levels in patients...
0 Reacties 0 aandelen 814 Views 0 voorbeeld
Sponsor